Skip to main navigation Skip to search Skip to main content

Usefulness and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention (from the TRACER trial)

  • Marco Valgimigli
  • , Pierluigi Tricoci
  • , Zhen Huang
  • , Philip Aylward
  • , Paul Armstrong
  • , F Van De Werf
  • , Sergio Leonardi
  • , Harvey White
  • , Petr Widimsky
  • , Robert Harrington
  • , Angel Cequier
  • , Edmond Chen
  • , Yuliya Lokhnygina
  • , Lars Wallentin
  • , John Strony
  • , Kenneth Mahaffey
  • , David Moliterno

    Research output: Contribution to journalArticlepeer-review

    16 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Usefulness and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention (from the TRACER trial)'. Together they form a unique fingerprint.
    Sort by

    Medicine and Dentistry

    Pharmacology, Toxicology and Pharmaceutical Science